Global Cannabis Testing Market Share expected to register at a CAGR of 10.5% By 2033

According to Custom Market Insights, the global cannabis testing market size is expected to increase from its anticipated value of USD 1.5 billion in 2021 to USD 3.0 billion by 2030, with a compound annual growth rate (CAGR) of around 10.5% from 2022 to 2030.

A number of factors are driving and restraining the market for cannabis testing. The report examines how these factors may affect demand throughout the projected period and examines the market for cannabis testing on a global scale.

Browse the full “Cannabis Testing Market By Types of Services (Potency Testing, Terpene Profiling, Heavy Metal Testing, Pesticide Screening, Microscopy Testing, Residual Solvent Screening, & Others), By End-User Services (Cannabis Drug Manufacturers, Cannabis Cultivators/Growers, & Others), And By Regions – Global & Regional Industry Perspective, Comprehensive Analysis, and Forecast 2023–2032” report at https://www.custommarketinsights.com/report/cannabis-testing-market/

Cannabis Testing Market: Overview

Cannabis sativa, the hemp plant, contains pharmacologically potent substances called cannabinoids. Cannabis is made up of dried cannabis Sativa as well as cannabis indica plant parts such as leaves, flowers, stems, and seeds. Since ancient times, this plant has been used medicinally, primarily as an anti-inflammatory or to treat pain, anxiety, or agitation. Cannabis is one of the most often used narcotics worldwide and is rising in demand. Cannabis drug testing is becoming more and more common in the legal, sports, and pharmaceutical industries. All batches of cannabis flowers and products ought to undergo sampling and analysis by authorized laboratories before delivery to retailers. For what must be evaluated and displayed on cannabis product labeling, various states and regions have set their standards and laws. For the projected period, rising certifications for cannabis-based medications are anticipated to drive market expansion for cannabis testing services globally.

Cannabis Testing Market: Growth Factors

Over the projection period, the worldwide cannabis testing services market is anticipated to rise due to the increased focus of key industry participants on new product releases. Permitting marijuana for medicinal use will also create new growth prospects for testing labs, resulting in significant growth in the cannabis testing market throughout the projected period. Medical cannabis has proven useful in treating several medical conditions, such as nausea brought on by chemotherapy, AIDS-related hunger stimulation, movement disorders muscle spasm control, as well as glaucoma intraocular pressure reduction. On the other side, a significant factor impeding the expansion of the worldwide for cannabis testing services market during the forecast period is the absence of standardized testing methodologies. Facilities for cannabis quality control testing are required due to the increasing requirement for secure cannabis products. However, several items fall short of the required standards.

Segmental Overview

The market’s leader in terms of service type and potency testing services is anticipated to experience rapid growth throughout the anticipated time frame. The market is predominantly being driven by a rise in the demand for analyzing the potency of different cannabinoids, especially CBD (Cannabidiol) & Tetra hydro cannabinol (THC) in developed cannabis, as well as a rise in the utilization of effective potency testing methods such as High-Performance Liquid Chromatography (HPLC) and Gas Chromatography (GC) for testing samples.

Regional Overview

All through the entire projection period, North America is anticipated to lead the market as a whole. The high frequency of chronic illnesses in the area, favorable laws, and the existence of big businesses are all contributing factors to market growth. Europe is the second-largest market for cannabis testing, following North America. The majority of the funding for this sector comes from Germany, the United Kingdom, Spain, and the rest of Europe. The market in the region is growing as a result of factors like increased cannabis clinical trials carried out by significant pharma companies in Europe.

Report Scope

Key Players Insights

The report offers an in-depth competitive analysis of these key industry players in the cannabis testing market, including their company profiles, recent developments, and significant business strategies. Thermo Fisher Scientific Inc., Merck KGaA, Shimadzu Corp., PerkinElmer Inc., Steep Hill Labs Inc., CB Scientific Inc., Alpha-CAT, Orange Photonics Inc., Gobi Labs, MyDx Inc., SC Laboratories Inc., Restek Corp., Waters Corp., and PharmLabs LLC are a few of the participants.

Some of the prominent players in the Global Cannabis Testing Market:

• Saskatchewan Research Council (SRC)
• SC Labs
• Steep Hill, Inc.
• SGS Canada Inc.
• CW ANALYTICAL

The Global Cannabis Testing Market is segmented as follows:

By Product and Software Analysis 

• Analytical Instruments
• Consumables
• Software

By Testing Procedures Analysis 

• Residual Solvent Screening
• Terpene Profiling
• Potency Testing
• Genetic Testing
• Pesticide Screening
• Heavy Metal Testing
• Microbial Analysis

By End-User Analysis 

• Laboratories
• Cannabis Cultivators
• Research Institutes
• Drug Manufacturers
• Dispensaries

On the basis of Geography

North America

• The U.S.
• Canada
• Mexico

Europe

• France
• The UK
• Spain
• Germany
• Italy
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America